# (68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors

> **NCT05798273** · NA · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Malignant Brain Tumors

## Interventions

- **PROCEDURE:** intra-arterial injection
- **DEVICE:** synchronous PET/MRI scan
- **OTHER:** Radiopharmacon Contrast agent

## Key facts

- **NCT ID:** NCT05798273
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-03-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05798273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05798273, "(68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05798273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*